Revolutionary Genome Sequencing Technologies - The $1000 Genome (R21)

The summary for the Revolutionary Genome Sequencing Technologies - The $1000 Genome (R21) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Revolutionary Genome Sequencing Technologies - The $1000 Genome (R21): -Purpose. The National Human Genome Research Institute (NHGRI) solicits grant applications to develop novel technologies that will enable extremely low-cost DNA sequencing. Current technologies are able to produce the sequence of a mammalian-sized genome of the desired data quality for $5 to $10 million; the goal of this initiative is to reduce costs by at least four orders of magnitude, so that a mammalian-sized genome could be sequenced for approximately $1000. Substantial fundamental research is needed to develop the scientific and technological knowledge underpinning such a major advance. Therefore, it is anticipated that the long-term goals of this FOA may be achieved in about ten years. -Applicants may propose to develop full-scale sequencing systems, or to investigate key components of such systems. Such independent proposals are an important path for pursuing novel, high risk/high pay-off ideas. -Mechanism of Support. This Funding Opportunity Announcement (FOA) will utilize the Exploratory/Developmental Grants (R21) grant mechanism and runs in parallel with FOAs of identical scientific scope (RFA-HG-06-020, RFA-HG-06-022, RFA-HG-06-023, RFA-HG-06-024) that solicit applications under the R01, R21/R33, Small Business Innovation Research (SBIR [R43/R44]) and Small Business Technology Transfer (STTR [R41/R42]) grant mechanisms.
Federal Grant Title: Revolutionary Genome Sequencing Technologies - The $1000 Genome (R21)
Federal Agency Name: National Institutes of Health
Grant Categories: Health
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-HG-06-021
Type of Funding: Grant
CFDA Numbers: 93.172
CFDA Descriptions: Human Genome Research
Current Application Deadline: No deadline provided
Original Application Deadline: Nov 25, 2006
Posted Date: Sep 28, 2006
Creation Date: Sep 28, 2006
Archive Date: Dec 25, 2006
Total Program Funding: $2,000,000
Maximum Federal Grant Award: $200,000
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
State governments For profit organizations other than small businesses Public and State controlled institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Small businesses Others (see text field entitled "Additional Information on Eligibility" for clarification) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education
Additional Information on Eligibility
Foreign institutions are eligible to apply. Eligible agencies of the Federal Government can apply. Faith-based or community-based organizations can apply. Applicants may submit more than one application, provided each application is scientifically distinct.
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
NIH OER Webmaster
[email protected]
[email protected] If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Similar Government Grants
Addressing Health Inequities in Clinical Diagnostics (R41/R42 Clinical Trials Not Allowed)
Addressing Health Inequities in Clinical Diagnostics (R43/R44 Clinical Trials Not Allowed)
NHGRI Technology Development Coordinating Center (U24 Clinical Trial Not Allowed)
Solutions to Enable Regional Genomic Medicine eConsult Services (R41/R42 Clinical Trial Op...
Research on the Impact of and Methods for Implementing Regional Genomic Medicine eConsult ...
Near-Term Technology Development for Genome Sequencing - SBIR (R43/R44)
Near-Term Technology Development for Genome Sequencing - STTR (R41/R42)
Revolutionary Genome Sequencing Technologies - The $1000 Genome - SBIR (R43/R44)
More Grants from the National Institutes of Health
Botanical Dietary Supplements Translational Research Teams (RM1 Clinical Trial Required)
Support for Research Excellence (SuRE) Award (R16 Clinical Trial Not Allowed)
Support for Research Excellence First Independent Research (SuRE-First) Award (R16 - Clin...
Research on the Neuro-Immune Axis in the context of HIV and Substance Use (R01 Clinical Tr...
Limited Competition: Research Resource for Natural Product Nuclear Magnetic Resonance Data...

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2024 FederalGrants.com